,i #aaith ,,congress #b;d ,session ,h4 ,r4 #hbfi ,,in ,,the ,,house ,,of ,,representatives ,april #ad1 #bjbf,mr4 ,mc,cormick 7for himself and ,ms4 ,de,lauro7 introduced the following bill2 which was referred to the ,committee on ,ways and ,means1 and in addition to the ,committee on ,energy and ,commerce1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act to require drug labeling to include original manufacturer and supply chain information4 #a4 ,short title ,this ,act may be cited as the ,consumer ,labeling for ,enhanced ,,api ,reporting and ,legitimate ,accountability for ,base ,entity ,listings ,act or the ,,clear ,,labels ,act4 #b4 ,require drug labeling to include original manufacturer and supply chain information ,section #ejb7;b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #ceb7;b77 is amended to read as follows3 7b7 7#a7 ,if it is a finished drug product in a package form1 unless it bears a label containing-- 7,a7 the name1 place of business1 and unique facility identifier of the manufacturer1 packer1 or distributor or a link1 barcode1 ,,qr code1 or other means to access a searchable electronic portal containing such information2 and 7,b7 an accurate statement of the quantity of the contents in terms of weight1 measure1 or numerical count1 provided that under this clause reasonable variations shall be permitted1 and exemptions as to small packages shall be established1 by regulations prescribed by the ,secretary4 7#b7 ,if it is an active pharmaceutical ingredient1 unless any accompanying label and certificate of analysis contains the name1 place of business1 and unique facility identifier of the original manufacturer4 7#c7 7,a7 ,if it is a finished drug product1 unless its labeling contains the name1 place of business1 and unique facility identifier of-- 7i7 the original manufacturer of each active pharmaceutical ingredient2 7ii7 the original manufacturer of the finished drug product2 and 7iii7 the packer or distributor1 if any1 or a link1 barcode1 ,,qr code1 or other means to access a searchable electronic portal containing such information4 7,b7 ,in the case of a finished drug product for which there are multiple potential different manufacturers of the active pharmaceutical ingredient1 the requirements of this subparagraph shall be satisfied if all such manufacturers of active pharmaceutical ingredients for the drug product are identified in the labeling or the searchable electronic portal4 7#d7 ,a manufacturer1 packer1 or distributor required to furnish information under subparagraphs 7#a71 7#b71 and 7#c71 in addition to making such information available electronically1 as applicable1 shall make such information available through a package insert1 or in paper copy to any individual who requests such a copy4 7#e7 ,for purposes of this paragraph1 the term original manufacturer1 means the single last establishment to conduct substantial manufacturing activities prior to introduction of the active pharmaceutical ingredient or finished drug product into interstate commerce4 7#f7 ,the ,secretary shall issue regulations to implement subparagraphs 7#b7 and 7#c7 and may provide for reasonable variations in the implementation of1 or an alternative placement for1 the labeling requirements under such subparagraphs1 including by electronic means4 ,such regulations shall take effect on a date determined by the ,secretary and not earlier than #a year after the date of publication of the final regulations1 and shall apply with respect to drugs manufactured on or after the effective date of such regulations4 4 #c4 ,exemption from customs country of origin marking requirement ,section #cjd of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #acjd7 is amended by adding at the end the following3 7m7 ,marking of certain finished drug products ,the marking requirements of subsections 7a7 and 7b7 shall not apply to articles that are finished drug products and are marked in accordance with the requirements of section #ejb7;b77#c77;,a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act4 4